中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib

文献类型:期刊论文

作者Xu, X.1,2,3; Li, N.3; Fan, Y.2,3
刊名JOURNAL OF THORACIC ONCOLOGY
出版日期2022-09-01
卷号17
ISSN号1556-0864
关键词ALK non-small cell lung cancer (NSCLC) leptomeningeal metastases (LM)
WOS研究方向Oncology ; Respiratory System
语种英语
出版者ELSEVIER SCIENCE INC
WOS记录号WOS:000858678101221
源URL[http://ir.hfcas.ac.cn:8080/handle/334002/129779]  
专题中国科学院合肥物质科学研究院
作者单位1.Zhejiang Chinese Med Univ, Hangzhou, Peoples R China
2.Chinese Acad Sci, Hangzhou, Peoples R China
3.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China
推荐引用方式
GB/T 7714
Xu, X.,Li, N.,Fan, Y.. Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib[J]. JOURNAL OF THORACIC ONCOLOGY,2022,17.
APA Xu, X.,Li, N.,&Fan, Y..(2022).Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib.JOURNAL OF THORACIC ONCOLOGY,17.
MLA Xu, X.,et al."Coexistence of a Novel NBAS-ALK, EML4-ALK Double-Fusion in a Lung Adenocarcinoma Patient With LM and Response to Ensartinib".JOURNAL OF THORACIC ONCOLOGY 17(2022).

入库方式: OAI收割

来源:合肥物质科学研究院

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。